Today: 27 April 2026
Browse Category

Stock Market 20 December 2025

Evolution Mining Limited (ASX:EVN) Stock: Latest News, EVN Share Price Forecasts, and Analyst Outlook (20 December 2025)

Evolution Mining Limited (ASX:EVN) Stock: Latest News, EVN Share Price Forecasts, and Analyst Outlook (20 December 2025)

Evolution Mining closed at A$12.62 on December 19, near its 52-week high of A$12.81, with a market cap around A$25.6 billion and P/E near 27. The company awarded a five-year underground mining contract at Cowal to Redpath, targeting full production by July 2026. Cowal also received full compliance under the International Cyanide Management Code.
20 December 2025
··
MCE Holdings Outlook (Dec 20, 2025): HLIB Keeps “Buy” as New Revenue Streams, Auto Hub and Perodua EV Supply Chain Set Up a Stronger 2026

MCE Holdings Outlook (Dec 20, 2025): HLIB Keeps “Buy” as New Revenue Streams, Auto Hub and Perodua EV Supply Chain Set Up a Stronger 2026

MCE Holdings reported a 13.6% drop in 1QFY2026 net profit to RM4.19 million, with revenue down 4.6% to RM39.52 million, citing reduced orders and higher transition costs. No dividend was declared. Shares last traded at RM1.54. Hong Leong Investment Bank maintained its BUY call, expecting new revenue streams and model launches to boost upcoming quarters.
20 December 2025
··
ANZ Group Holdings Limited Stock (ASX: ANZ): $250m Federal Court Penalty, AGM Pay “Strike”, Dividend Paid — and Analyst Forecasts as of 20 Dec 2025

ANZ Group Holdings Limited Stock (ASX: ANZ): $250m Federal Court Penalty, AGM Pay “Strike”, Dividend Paid — and Analyst Forecasts as of 20 Dec 2025

Australia’s Federal Court ordered ANZ to pay A$250 million in penalties for misconduct across institutional and retail banking, the largest such penalty secured by ASIC. The ruling covers failures in government bond management, customer hardship responses, misleading statements on interest rates, and fees charged to deceased customers. ANZ shares last traded at A$36.03, near analyst target ranges. Nuno Matos recently took over as CEO.
20 December 2025
··
Fortescue Ltd (ASX: FMG) Stock Today: Share Price Pullback, Alta Copper Deal, Green Iron Push and 2026 Iron Ore Forecasts (Dec. 20, 2025)

Fortescue Ltd (ASX: FMG) Stock Today: Share Price Pullback, Alta Copper Deal, Green Iron Push and 2026 Iron Ore Forecasts (Dec. 20, 2025)

Fortescue shares fell 3.23% to A$21.88 on Friday, Dec. 19, with trading volume more than double the average, after hitting a 52-week high of A$23.38 on Dec. 11. The drop came as the company faces a tougher iron ore market, a planned Alta Copper buyout, and a shift toward green iron and electrification projects.
20 December 2025
···
Northern Star Resources (ASX:NST) Stock: Latest News, Share Price Forecasts, and What to Watch in 2026

Northern Star Resources (ASX:NST) Stock: Latest News, Share Price Forecasts, and What to Watch in 2026

Northern Star Resources shares closed at A$25.82 on 19 December 2025, down 3.37% after gold prices slipped. The company announced a A$225 million exploration budget for FY26, focusing 73% on in-mine growth across Kalgoorlie, Yandal, and Pogo. Gold surged 64% in 2025 to a record US$4,381/oz, but Northern Star’s stock remains closely tied to bullion sentiment and operational execution.
20 December 2025
··
Commonwealth Bank of Australia Stock (ASX:CBA): Latest Share Price, News, Analyst Forecasts and 2026 Outlook (20 Dec 2025)

Commonwealth Bank of Australia Stock (ASX:CBA): Latest Share Price, News, Analyst Forecasts and 2026 Outlook (20 Dec 2025)

Commonwealth Bank of Australia closed at A$157.75 on 19 December 2025, up 1.77%, with a market cap near A$263.76 billion. The stock remains 18% below its 52-week high, as analysts debate its valuation amid steady RBA rates at 3.60%. CBA paid A$792,000 in penalties after an ACCC resolution over Consumer Data Right rule breaches. The next RBA meeting is set for early February 2026.
20 December 2025
·
PLS Group Limited Stock (ASX:PLS): Latest News, Analyst Forecasts, Price Targets and Key Catalysts as of 20 December 2025

PLS Group Limited Stock (ASX:PLS): Latest News, Analyst Forecasts, Price Targets and Key Catalysts as of 20 December 2025

PLS Group Limited, formerly Pilbara Minerals, named Alex Willcocks as CFO effective May 2026 and announced Robert Nicholson will join the board in January 2026, replacing Steve Scudamore. The company’s shares last traded at A$3.93, valuing it at about A$12.65 billion. PLS continues to focus on its Pilgangoora operation and growth projects in Brazil and South Korea.
20 December 2025
·
Australia Stock Market Today (20 December 2025): ASX 200 Ends Week Higher as Tech and Banks Rebound, Uranium Surges, and ANZ Hit with Record $250m Penalty

Australia Stock Market Today (20 December 2025): ASX 200 Ends Week Higher as Tech and Banks Rebound, Uranium Surges, and ANZ Hit with Record $250m Penalty

Australia’s stock market is closed Saturday, December 20, 2025, after the S&P/ASX 200 rose 0.47% Friday, led by tech and banks. Small caps outperformed, with the Small Ordinaries up 1.9%. Despite the rebound, the weekly streak ended. ANZ faced a record penalty, and Netwealth fell on compensation concerns.
20 December 2025
··
Vertex Pharmaceuticals (VRTX) Stock After Hours on Dec. 19, 2025: Today’s News, Analyst Forecasts, and What to Know Before Monday’s Market Open

Vertex Pharmaceuticals (VRTX) Stock After Hours on Dec. 19, 2025: Today’s News, Analyst Forecasts, and What to Know Before Monday’s Market Open

Vertex Pharmaceuticals closed up 1.97% at $456.20 Friday, ending a three-day slide on volume of about 5.56 million shares, far above its 50-day average. After-hours trading was quiet, with the stock quoted near $456.49 as of 7:40 p.m. ET. No major company news drove the move; trading reflected broad market gains and heavy year-end positioning.
20 December 2025
··
Linde (LIN) Stock After the Bell on Dec. 19, 2025: After-Hours Move, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Linde (LIN) Stock After the Bell on Dec. 19, 2025: After-Hours Move, Today’s Headlines, Analyst Forecasts, and What to Watch Before the Next Market Open

Linde plc closed at $421.43 on December 19, up 0.58%, and edged higher to $422.45 in after-hours trading. Volume reached about 6 million shares, nearly double its average. No new company news was posted; trading reflected broader market positioning and options expiration. Linde remains about 13% below its 52-week high.
20 December 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 20.12.2025

ICICI Prudential AMC is set to list on the NSE with an expected price of ₹2,675-₹2,690, reflecting a 20% premium in grey market trading. UPS shares have climbed 10% in a month to $102.08 but remain negative for the year, with analysts citing execution risk and potential pullbacks if momentum fades.
20 December 2025
·
PepsiCo Stock (PEP) After Hours: Shares Dip After the Dec. 19, 2025 Close — Key News, Fresh Analyst Forecasts, and What to Watch Before the Next Session

PepsiCo Stock (PEP) After Hours: Shares Dip After the Dec. 19, 2025 Close — Key News, Fresh Analyst Forecasts, and What to Watch Before the Next Session

PepsiCo shares closed at $148.16 on Friday, down 0.81%, and slipped further to about $148.00 in after-hours trading, even as major indexes rose. The move came on heavy “triple witching” volume. Bank of America raised its price target for PepsiCo to $164 but kept a Neutral rating, citing questions about consumer demand in 2026.
20 December 2025
·
Coinbase Stock (COIN) After Hours on Dec. 19, 2025: Lawsuits, Stablecoin Deals and Bitcoin Moves to Watch Before the Next Market Open

Coinbase Stock (COIN) After Hours on Dec. 19, 2025: Lawsuits, Stablecoin Deals and Bitcoin Moves to Watch Before the Next Market Open

Coinbase closed Friday, Dec. 19, 2025, at $245.12, up 2.47%, with about 10.61 million shares traded, then edged to $245.78 after hours. The move followed a volatile week tied to Bitcoin’s rebound and news that Coinbase filed federal lawsuits against Connecticut, Michigan, and Illinois over regulation of prediction markets. The company plans to launch CFTC-regulated event contracts in January 2026.
20 December 2025
··
Carnival (CCL) Stock Surges After Earnings, Dividend Return and NYSE-Only Listing Plan — What to Know Before the Next Market Open

Carnival (CCL) Stock Surges After Earnings, Dividend Return and NYSE-Only Listing Plan — What to Know Before the Next Market Open

Carnival Corporation shares closed up 9.81% at $31.12 on December 19, 2025, after reporting record annual revenue of $26.6 billion and reinstating its quarterly dividend at $0.15 per share. The company also announced plans to unify its dual-listed structure and exit the London Stock Exchange. Trading volume topped 84 million shares. After-hours trading was flat near $31.13.
20 December 2025
···
Sandisk (SNDK) Stock After Hours on Dec. 19, 2025: What’s Driving the Move and What to Watch Before the Next Market Open

Sandisk (SNDK) Stock After Hours on Dec. 19, 2025: What’s Driving the Move and What to Watch Before the Next Market Open

Sandisk shares closed Friday up 8.27% at $237.61, then gained another 0.75% to $239.39 in after-hours trading on volume of 1.43 million shares. The stock swung between $221.00 and $243.71 during the session. Activity tracked sector momentum after Micron’s earnings and coincided with Quadruple Witching options expiry. U.S. markets reopen Monday, Dec. 22.
20 December 2025
·
Biogen Stock (BIIB) After-Hours on Dec. 19, 2025: Why Shares Jumped, Where They Closed After the Bell, and What to Watch Before the Next Market Open

Biogen Stock (BIIB) After-Hours on Dec. 19, 2025: Why Shares Jumped, Where They Closed After the Bell, and What to Watch Before the Next Market Open

Biogen shares closed up 2.88% at $174.80 Friday, with trading volume surging to about 15 million shares, far above the 50-day average. The move followed bullish analyst commentary from RBC Capital, which reiterated an “Outperform” rating and a $210 price target. After-hours, BIIB edged higher to $176.23. Renewed focus on Alzheimer’s treatments and pipeline prospects drove activity.
20 December 2025
·
1 … 893 894 895 896 897 … 1,393

Stock Market Today

  • Options Traders Reflect on Toughest Lessons Learned
    April 27, 2026, 3:59 PM EDT. Options traders discuss valuable insights gained from difficult experiences in the derivatives market. Trading options-contracts granting the right to buy or sell an asset at a set price-requires understanding complex risks. Many traders highlight the importance of discipline, managing losses, and resisting emotional decisions. These lessons often come after costly mistakes, underlining how quickly volatility and leverage can amplify losses. Industry voices stress education and strategy adjustments as key to survival and success in options trading.

Latest article

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

27 April 2026
Intellia Therapeutics reported its CRISPR drug lonvo-z cut hereditary angioedema attacks by 87% versus placebo in a late-stage trial, with 62% of treated patients attack- and therapy-free over six months. The company has started a rolling U.S. approval application. No serious adverse events were reported. Intellia shares fell 0.9% to $13.51 after initial gains.
U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

27 April 2026
U.S. Energy Corp. signed a five-year helium sales deal with an unnamed global industrial gas company, securing a buyer for output from its planned Big Sky Carbon Hub in Montana. The contract covers up to 1.2 million cubic feet a month at a fixed $285 per thousand cubic feet, with inflation adjustments starting March 2028. U.S. Energy shares rose 20.8% to $1.12 on heavy volume. The agreement is “take-or-pay,” with the buyer handling pickup at the plant.
Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

27 April 2026
Veradermics shares rose 40% Monday after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial of 519 men. Patients taking the drug saw average hair count increases of 30.3 to 33.0 hairs per square centimeter over six months, compared to 7.3 for placebo. No treatment-related serious or heart-related adverse events were reported.
Go toTop